β-Nicotinamide mononucleotide protects against hypervirulent Klebsiella pneumoniae bloodstream infection and liver injury
mSphere · 2025
DOI: 10.1128/msphere.00361-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Zubai Cao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University,…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Nicotinamide Mononucleotide, Liver Abscess. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In clinical practice, hypervirulent Klebsiella pneumoniae (hvKP) often causes bloodstream infections (BSI) and liver abscesses; however, the mechanism of hvKP-induced liver abscess formation remains unclear. β-Nicotinamide mononucleotide (NMN) has been reported to have potential therapeutic effects on sepsis, but its impact on hvKP BSI is still unclear. Supplementation with NMN improved the survival rate of hvKP BSI, and the protective effects of NMN disappeared after macrophage depletion. NMN treatment can reduce NF-κB signaling pathway activation in bone marrow-derived macrophages (BMDM) after hvKP infection, as well as the transcription of Il6 , Il1b , Tnf , and Cxcl2 . NMN, combined with antibiotic therapy, blocked the formation of hvKP liver abscesses. The treatment regimen of NMN combined with antibiotics effectively reduced the levels of inflammatory factors in the liver, inhibited the activation of the NF-κB signaling pathway, and reduced the infiltration of neutrophils into the liver. These results indicate that NMN exerts a protective effect against hvKP BSI by inhibiting excessive inflammatory response, and NMN has therapeutic potential for preventing liver injury caused by hvKP. IMPORTANCE This study found that β-nicotinamide mononucleotide (NMN) can protect mice against hvKP BSI via inhibiting the NF-κB signaling pathway activation. Supplementing NMN with antibiotic treatment alleviated the inflammatory response of the liver and reduced the formation of liver abscess, providing insight into the mechanism of liver abscess research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Anhui Province Key Laboratory of Infectious Diseases & Institute of Bacterial Resistance, Anhui Medical University, Hefei, China.
ORCID-Profile: Zubai Cao, Yanyan Liu, Jiabin Li
Zitieren
APA
Cao, Z., Meng, B., Chen, J., Ge, R., Liu, Y., & Li, J. (2025). β-Nicotinamide mononucleotide protects against hypervirulent Klebsiella pneumoniae bloodstream infection and liver injury. mSphere. https://doi.org/10.1128/msphere.00361-25
Vancouver
Cao Z, Meng B, Chen J, Ge R, Liu Y, Li J. β-Nicotinamide mononucleotide protects against hypervirulent Klebsiella pneumoniae bloodstream infection and liver injury. mSphere. 2025. doi:10.1128/msphere.00361-25
BibTeX
@article{Cao2025,
author = {Cao, Zubai and Meng, Bao and Chen, Jie and Ge, Ruomu and Liu, Yanyan and Li, Jiabin},
title = {β-Nicotinamide mononucleotide protects against hypervirulent Klebsiella pneumoniae bloodstream infection and liver injury},
journal = {mSphere},
year = {2025},
doi = {10.1128/msphere.00361-25}
}
EUVIMED